Storia in 2 fonti

Kalshi and Polymarket now let you bet on drug approvals, and not everyone is thrilled about it

Kalshi and Polymarket now offer prediction markets on FDA drug approvals and clinical trials, raising serious concerns about insider trading and

Raccontata da

cryptobriefing.com

medpagetoday.com

Confronto fonti

2 prospettive sulla stessa storia

AI · summaries

cryptobriefing.comStai leggendo1 mese fa

Kalshi and Polymarket now let you bet on drug approvals, and not everyone is thrilled about it

Kalshi and Polymarket launched prediction markets for FDA drug approvals and Phase 3 trials, with $100K+ volume. CFTC regulation (Kalshi) vs. crypto anonymity (Polymarket) creates insider-trading risks—a new monetization channel for nonpublic pharma trial data.

originale

medpagetoday.com1 mese fa

Opinion | Can a Betting Market Offer Hope to a Cancer Patient?

As we embrace the power of collective knowledge, we must remember that numbers are just numbers

Leggi questa versione → originale

Timeline cronologica

martedì 28 luglio 2026·cryptobriefing.com
Kalshi and Polymarket now let you bet on drug approvals, and not everyone is thrilled about it
Kalshi and Polymarket now offer prediction markets on FDA drug approvals and clinical trials, raising serious concerns about insider trading and
giovedì 30 luglio 2026·medpagetoday.com
Opinion | Can a Betting Market Offer Hope to a Cancer Patient?
As we embrace the power of collective knowledge, we must remember that numbers are just numbers